AAD 2026Abstract 73341
Effect of Risankizumab Versus Deucravacitinib on Psoriasis-Related Symptoms and Quality of Life in Patients With Moderate Plaque Psoriasis
Results From the IMMpactful Trial at Week 16
Soung J, Magnolo N, Frew J, Constanzo A, Moore AY, Xie J, Kaplan B, Stakias V, Espaillat R, Patel M, Warren RB
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Psoriasis
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.718 · Not in PubMed: details from Crossref